Academic Journal Retractions and the COVID-19 Pandemic
- PMID: 33949228
- PMCID: PMC8114243
- DOI: 10.1177/21501327211015592
Academic Journal Retractions and the COVID-19 Pandemic
Abstract
The 2020 COVID-19 pandemic has produced an unprecedented amount of scientific research, with over 100,000 articles on the SARS-COV2 virus or the associated pandemic published within the first year. To effectively disseminate such a large volume of research, some academic journal publishers altered their review criteria, and many articles were made available before undergoing a traditional review process. However, with this rapid influx of information, multiple COVID-19 articles have been retracted or withdrawn. Some researchers have expressed concern that these retractions call into question the validity of an expedited review process and the overall quality of the larger body of COVID-19 research. We examined 68 removed articles and determined that many of the articles were removed for unknown reasons (n = 22) or as duplications (n = 12); 24 papers were retracted for more significant reasons (data integrity, plagiarism, reporting or analysis, and IRB or privacy issues). The majority of removed papers were from the USA (n = 23) and China (n = 19).
Keywords: COVID-19; SARS-CoV-2; coronavirus; research quality; retraction.
Conflict of interest statement
References
- 
    - Else H. How a torrent of COVID science changed research publishing - in seven charts. Nature. 2020;588:553. - PubMed
 
- 
    - Callaway E. Will the pandemic permanently alter scientific publishing? Nature. 2020;582:167-168. - PubMed
 
- 
    - Palayew A, Norgaard O, Safreed-Harmon K, Andersen TH, Rasmussen LN, Lazarus JV. Pandemic publishing poses a new COVID-19 challenge. Nat Hum Behav. 2020;4:666-669. - PubMed
 
MeSH terms
Substances
LinkOut - more resources
- Full Text Sources
- Other Literature Sources
- Medical
- Miscellaneous
 
        